PSGL-1

PSGL-1 Overview

English NameP-selectin glycoprotein ligand-1Approved Drugs0
Drugs in Clinical Trials4Target SynonymP-selectin glycoprotein ligand 1,PSGL-1,SELPLG,Selectin P Ligand,Cutaneous Lymphocyte-Associated Associated Antigen,CD162 Antigen,CD162,PSGL1,CLA
Highest Development StagePhase 2 Clinical
English NameP-selectin glycoprotein ligand-1
Target SynonymP-selectin glycoprotein ligand 1,PSGL-1,SELPLG,Selectin P Ligand,Cutaneous Lymphocyte-Associated Associated Antigen,CD162 Antigen,CD162,PSGL1,CLA
Approved Drugs0
Drugs in Clinical Trials4
Highest Development StagePhase 2 Clinical

PSGL-1 Product List

  • Product Category

    Protein (2)

  • Product Status

    Launched (2)

  • Species

    Human (2)

  • Tag

    His Tag (1)His Tag & Avi Tag (1)

  • Conjugate

    Unconjugated (1)Biotin-labeled (1)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeature
PS1-H52H9
Human
HEK293
Human PSGL-1 / CD162 Protein, His Tag
PS1-H82E4
Human
HEK293
Biotinylated Human PSGL-1 / CD162 Protein, His,Avitag™
Total: 2
  • 1

PSGL-1 Background

P-selectin glycoprotein ligand 1 (PSGL-1) is also known as Selectin P ligand (SELPLG), CD antigen CD162. PSGL-1 is disulfide-linked homodimer which is the high affinitycounter-receptor for P-selectin on expressed on activated endothelial cells and platelets. PSGL-1 / SELPLG interacts with P-, E- and L-selectins, through their lectin/EGF domains, is required for promoting recruitment and rolling of leukocytes. These interactions require sialyl Lewis X glycan modification but there is a differing dependence for tyrosine sulfations. Dimerization appears not to be required for P-selectin/SELP binding. PSGL-1 can interact with SNX20, MSN and SYK. PSGL-1 / SELPLG mediate the activation of SYK by SELPLG.

PSGL-1 Synonyms

PSGL1,CD162,SELPLG,Selectin P ligand

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
CepeprubartSelK-2Phase 2 ClinicalSelexysAsthma; Pulmonary Disease, Chronic Obstructive; Venous Thromboembolism
Details
LeiolizumabAbGn 168H2; AbGn-268; AbGn-168H2; ALTB-268Phase 2 ClinicalAltrubio IncArthritis, Psoriatic; Colitis, Ulcerative
Details
NeihulizumabAbGn-168; AbGn-168H; ALTB-168Phase 1 ClinicalAltrubio IncArthritis, Psoriatic; Colitis, Ulcerative; Graft vs Host Disease; Plaque psoriasis; Psoriasis
Details
SSGJ-617SSGJ-617; SSGJ617; 61X; VTX-0811; 617Phase 1 ClinicalVerseau Therapeutics IncSolid tumours
Details
  • Overview
  • Product List
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland